These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 15945939)

  • 1. Assessing the clinical significance of anti-Cra and anti-M in a chronically transfused sickle cell patient.
    Leatherbarrow MB; Ellisor SS; Collins PA; Douglas DK; Eckrich RJ; Esty SS; Baldwin ML; Ness PM
    Immunohematology; 1988; 4(4):71-4. PubMed ID: 15945939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The production of red blood cell alloantibodies in mice transfused with blood from transgenic Fyb-expressing mice.
    Campbell-Lee SA; Liu J; Velliquette RW; Halverson GR; Shirey RS; Chaudhuri A; Reid ME; Ness PM; Baldwin WM
    Transfusion; 2006 Oct; 46(10):1682-8. PubMed ID: 17002623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfusion of multiple units of Js(b+) red blood cells in the presence of anti-Jsb in a patient with sickle beta-thalassemia disease and a review of the literature.
    Yuan S; Ewing NP; Bailey D; Salvador M; Wang S
    Immunohematology; 2007; 23(2):75-80. PubMed ID: 18004938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure to detect a prozoning anti-Fya in the serum of a chronically transfused patient.
    Sizemore JC; Sammons TD; Clanton JN
    Immunohematology; 1992; 8(2):44-6. PubMed ID: 15946056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of anti-Yt(b). Report of a case using a 51chromium red cell survival study.
    Levy GJ; Selset G; McQuiston D; Nance SJ; Garratty G; Smith LE; Goldfinger D
    Transfusion; 1988; 28(3):265-7. PubMed ID: 3285526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A retrospective analysis of the value of monocyte monolayer assay results for predicting the clinical significance of blood group alloantibodies.
    Arndt PA; Garratty G
    Transfusion; 2004 Sep; 44(9):1273-81. PubMed ID: 15318848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additional red blood cell alloantibodies after blood transfusions in a nonhematologic alloimmunized patient cohort: is it time to take precautionary measures?
    Schonewille H; van de Watering LM; Brand A
    Transfusion; 2006 Apr; 46(4):630-5. PubMed ID: 16584440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal blood grouping and antibody screening for safe transfusion.
    Makarovska-Bojadzieva T; Blagoevska M; Kolevski P; Kostovska S
    Prilozi; 2009 Jul; 30(1):119-28. PubMed ID: 19736535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of red-cell antigens and antibodies in Malawi.
    M'baya B; Mfune T; Mogombo E; Mphalalo A; Ndhlovu D; Knight RC
    Transfus Med; 2010 Jun; 20(3):196-9. PubMed ID: 20015059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of antibody following 51chromium survival studies.
    Esty SS; Wahl T; Zawisza J; Mallory D; Davey RJ
    Immunohematology; 1987; 3(1):6-8. PubMed ID: 15945886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two cases of autoantibodies that demonstrate mimicking specificity in the Duffy blood group system.
    Harris T
    Immunohematology; 1990; 6(4):87-91. PubMed ID: 15946003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired hemoglobin variants and exposure to glucose-6-phosphate dehydrogenase deficient red blood cell units during exchange transfusion for sickle cell disease in a patient requiring antigen-matched blood.
    Raciti PM; Francis RO; Spitalnik PF; Schwartz J; Jhang JS
    J Clin Apher; 2013 Aug; 28(4):325-9. PubMed ID: 23450789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Red cell antigen prevalence predicted by molecular testing in ethnic groups of South Texas blood donors.
    Aranda LI; Smith LA; Jones S; Beddard R
    Immunohematology; 2015; 31(4):166-73. PubMed ID: 27187198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cold autoimmune hemolytic anemia with auto-anti-AI specificity: 51chromium survival studies.
    McGinniss MH; Binder RA; Kales AN; Davey RJ
    Immunohematology; 1987; 3(2):20-2. PubMed ID: 15945892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of an anti-Dib assessed by flow cytometry.
    Leger R; Arndt P; Co A; O'Brien L; Garratty G
    Immunohematology; 1997; 13(3):93-6. PubMed ID: 15387776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful transfusion of antigen positive blood to alloimmunised patients using a monocyte monolayer assay.
    Noumsi GT; Billingsley KL; Moulds JM
    Transfus Med; 2015 Apr; 25(2):92-100. PubMed ID: 25828731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of anti-D in D- recipients transfused with D+ red blood cells.
    Yazer MH; Triulzi DJ
    Transfusion; 2007 Dec; 47(12):2197-201. PubMed ID: 17714422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An example of anti-LWa in a 10-month-old infant.
    Devenish A
    Immunohematology; 1994; 10(4):127-9. PubMed ID: 15945814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Red blood cell alloantibody frequency, specificity, and properties in a population of male military veterans.
    Tormey CA; Fisk J; Stack G
    Transfusion; 2008 Oct; 48(10):2069-76. PubMed ID: 18631165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and specificities of red blood cell alloantibodies in transfused Ugandans with different diseases.
    Natukunda B; Schonewille H; van de Watering L; Brand A
    Vox Sang; 2010 Feb; 98(2):167-71. PubMed ID: 19708889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.